ArticleBiological trace element research2025
Ferulic Acid Ameliorates Chromium-Induced Nephrotoxicity: Modulation of PERK/eIF2α/ATF4/CHOP, Nrf2, and Inflammatory Signaling.
Article in Biological trace element research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Protective effects of thymoquinone against hexavalent chromium-ınduced nephrotoxicity: a multiparametric evaluation of oxidative stress, ınflammation, ferroptosis- and apoptosis-related markers.Molecular and cellular biochemistry · 2026Article
- Toxicological Assessment of Cobalt-Chromium Dental Alloys: Ion Release, Cytotoxicity, and Possible Systemic Effects.Biological trace element research · 2026Article
- Polystyrene Nanoplastics induced placental toxicology by activating Keap1-mediated ferroptosis via METTL3-dependent m6A methylation.Cell biology and toxicology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Hexavalent chromium (HVC) is a highly toxic heavy metal that induces organ damage especially to the kidney. It induces tubular damage and glomerular dysfunction basically through triggering inflammation, redox imbalance, and apoptotic cell death. The current study aimed at investigating the possible protective ability of ferulic acid (FA) against HVC-induced nephrotoxicity employing male Wistar rats as an experimental model. The results revealed the ability of FA to suppress the HVC-evoked renal tissue injury and to improve the renal function, as evidenced by enhanced histopathological picture, reduced levels of the tubular injury biomarker KIM- 1, and the glomerular dysfunction biomarkers serum cystatin C and urea, along with boosted glomerular filtration rate. At the molecular level, FA suppressed HVC-induced inflammation, as indicated by decreased nuclear NF-κB p65 protein abundance and phosphorylation, and reduced cyclooxygenase- 2, IL- 1β, and TNF-α levels. FA significantly alleviated the HVC-induced redox imbalance as demonstrated by reduced lipids and DNA oxidation, upregulation of Nrf2 signaling, improved activity of the antioxidant enzymes thioredoxin reductase, catalase, and glutathione peroxidase, along with significant elevation of the reduced glutathione level. FA inhibited apoptosis in the HVC-intoxicated rats as evidenced by reduced activity of the apoptotic marker caspase- 3 and modulation of BAX and Bcl2 proteins. Interestingly, FA suppressed the unfolded protein response signaling molecules including PERK, eIF2α, ATF4, and CHOP, which play essential roles in induction of apoptosis and inflammation. Together, these results underscore the nephroprotective impact of FA against HVC-evoked nephrotoxicity and highlight PERK, eIF2α, ATF4, CHOP, Nrf2, and NF-κB as potential molecular targets.
Indexed as
Identifiers
40210814What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.